YourLawyer.com 1-800-LAW-INFO (1-800-529-4636)

Breast Cancer


AddThis Social Bookmark Button

Breast Cancer

Breast cancer is the most common malignancy in women and the second leading cause of cancer death (exceeded by lung cancer in 1985). Breast cancer is three times more common than all gynecologic malignancies put together. The incidence of breast cancer has been increasing steadily from an incidence of 1:20 in 1960 to 1:8 women today.

The American Cancer Society estimates that 211,000 new cases of invasive breast cancer will be diagnosed this year and 43,300 patients will die from the disease. Breast cancer is truly an epidemic among women and we don't know why.

Breast cancer is not exclusively a disease of women. For every 100 women with breast cancer, 1 male will develop the disease. The American Cancer society estimates that 1,600 men will develop the disease this year. The evaluation of men with breast masses is similar to that in women, including mammography.

The incidence of breast cancer is very low in the twenties (age) gradually increases and plateaus at the age of forty-five and increases dramatically after fifty. Fifty percent of breast cancer is diagnosed in women over sixty-five indicating the ongoing necessity of yearly screening throughout a woman's life.

Breast cancer is considered a heterogeneous disease, meaning that it is a different disease in different women, a different disease in different age groups and has different cell populations within the tumor itself. Generally, breast cancer is a much more aggressive disease in younger women. Autopsy studies show that 2% of the population has undiagnosed breast cancer at the time of death. Older women typically have much less aggressive disease than younger women.

Invasive lobular breast cancer affects about 10-15% of all women with breast cancer. It can occur at any age, but more commonly affects women in the 45-55 year age group. Men can also get invasive lobular breast cancer but this is very rare.

Invasive lobular breast cancer is generally no more serious than other types of breast cancer. However, it is sometimes found in both breasts at the same time and there is also a slightly greater risk of it occurring in the opposite breast at a later date.

If you or a loved one has taken Hormone Replacement Therapy drugs and been diagnosed with Breast cancer, please fill out the form at the right for a free case evaluation by a qualified defective drug attorney.

Breast CancerRSS Feed

Trans-Fats Implicated in Breast Cancer

Apr 14, 2008 | Parker Waichman Alonso LLP
European researchers reported this past Friday that trans-fats may raise the risk of breast cancer. The study found that women with the highest blood levels of trans-fats had about twice the risk of developing breast cancer as compared to women with the lowest levels. "At this stage, we can only recommend limiting the consumption of processed foods, the source of industrially produced trans-fatty acid," the researchers wrote in the American Journal of Epidemiology.  Breast cancer...

Hormone Replacement Therapy Even for Short Periods Raises Breast Cancer Risk

Jan 16, 2008 | Parker Waichman Alonso LLP
U.S. researchers reported this week that hormone replacement therapy (HRT) significantly raises the risk of an uncommon type of breast cancer.  The study found women who took combined estrogen/progestin HRT for three years or more had four times the usual risk of lobular breast cancer.  The study, published in the January issue of Cancer Epidemiology, Biomarkers and Prevention, is one of dozens of studies looking to clarify the dangers of taking HRT to treat menopause symptoms. ...

Breast Cancer Patients Miss Out on Appropriate Treatment Thanks to Inaccurate Tests

Jan 4, 2008 | Parker Waichman Alonso LLP
Faulty cancer tests might be keeping some breast cancer patients from getting appropriate treatment.  The American Cancer Society expected nearly 180,000 patients to be diagnosed with invasive breast cancer in the U.S. in 2007.  Tests help determine whether women with invasive breast cancer receive drugs such as Genentech Inc.'s Herceptin; GlaxoSmithKline PLC's Tykerb and a number of anti-hormone medications, including the generic tamoxifen; and newer treatments such as...

Breast Cancer Patients Not Getting Adequate Breast Reconstruction Information

Dec 26, 2007 | Parker Waichman Alonso LLP
Breast cancer patients are not getting all the information they need to make educated treatment decisions.  A new study—paid for by the National Cancer Institute—revealed most doctors don't discuss breast reconstruction options with women prior to cancer surgery, depriving them of key information that can impact whether to have an entire breast or just a lump removed.  One-third of the 1,178 women in the study—surveyed three months after surgery from 2001 to...

Mammogram Accuracy Depends on Physician, Study Says

Dec 13, 2007 | Parker Waichman Alonso LLP
Mammograms are not always an effective way of diagnosing breast cancer, and the accuracy of a mammogram is highly dependent on the physician who reads it.  A new three-state study led by Seattle's Group Health Cooperative revealed that even the most skilled radiologists fail to detect 20 percent of breast-cancer cases in diagnostic mammograms, which are conducted when cancer is suspected and when tumors would presumably be larger and easier to spot.  This revelation strengthens...

More Breast Cancer News

Breast Cancer
* Denotes required field.

Title

* First Name

* Last Name

* Email Address

* Phone Number

Cell Phone Number

Office Phone Number

Street Address

Apartment/Suite

City

State

Zip Code

Please provide the best method and times to contact you:

Date of birth of person injured
(mm-dd-yyyy):

If you believe breast cancer developed as the result of a drug (i.e. Prempro), please list drug:

Date you started taking the drug (mm-yyyy):

Date you stopped taking the drug (mm-yyyy):

If diagnosed with breast cancer, please indicate details of diagnosis:




Have any family members (sisters, mother, grandmothers) been diagnosed with breast cancer?


If yes, please describe which family member was diagnosed and the type of cancer that was diagnosed:

Have you been genetically screened for breast cancer?


If you have been screened for breast cancer, please describe results:

Other Info:

No Yes, I agree to the Parker Waichman Alonso LLP disclaimers.Click here to review all.

Yes, I would like to receive the Parker Waichman Alonso LLP monthly newsletter, InjuryAlert.

please do not fill out the field below.

Home | Defective Drugs | Medical Devices | Toxic Substances | Accidents | Product Liability | Malpractice | Diseases
Nursing Home Negligence | Food Poisoning | Other Topics | Contact
Statement of Clients' Rights | Site Map | ReNu with MoistureLoc | Vioxx | Mesothelioma | Permax | Dostinex | Composix Kugel Mesh X Large Patch
Ortho Evra | Fosamax | Personal Injury Lawyer | Fusarium Keratitis | Stevens Johnson Syndrome

© 2002-2008 YourLawyer.com. All Rights Reserved.

Please note that you are not considered a client until you have signed a retainer agreement and your case has been accepted by us.
Prior results do not guarantee or predict a similar outcome with respect to any future matter.
Attorney Advertising

Parker Waichman Personal Injury News